Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prenylated isoflavones for treatment of subjects with multidrug-resistant cancer

Prenylated isoflavones for treatment of subjects with multidrug-resistant cancer

US Patent 9974766 · Granted May 22, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc p2024
Targeted CD73 antibody and antibody-drug conjugate, and preparation method there2024
FGF21 variant, fusion protein and application thereof2023
Use of glycan as biomarkers for autoimmune diseases2021
Method of identifying a gene associated with a disease or pathological condition2020
Methods of treating cancer2020
Method of treating refractory rheumatoid arthritis associated with p53 mutation2020
Method of treating refractory rheumatoid arthritis associated with p53 mutation2020
Method of treating refractory rheumatoid arthritis associated with p53 mutation2020
Compounds that activate autophagy2020
Compounds that activate autophagy2020
Triterpenoid obtainable from hedera helix for treatment of neurodegenerative dis2019